The approval is based on a multi-center, randomized, double-blind, placebo-controlled phase III study to confirm the efficacy and safety of Stapokibart injection in treatment of adult patients with ...

50mcg/spray. Mometasone is a corticosteroid demonstrating potent anti-inflammatory properties. The precise mechanism of corticosteroid action on allergic rhinitis is not known. Treatment of ...

Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...

Antihistamines for allergic rhinitis have experienced major commercial ... the FDA would be reluctant to approve a steroid-based spray. Additionally, the incorrect use of the intranasal delivery ...

Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental ...

For patients with allergic rhinitis, twice-daily azelastine plus ... all treatments were administered as one spray twice daily to preserve blinding. The studies were sponsored by a company that ...

Ipratropium bromide nasal solution 0.06% is indicated for symptomatic relief of rhinorrhea associated with the common cold or ...

Allergic rhinitis is the inflammation of nasal passageways ... with saline or a saltwater solution from a neti pot or nasal ...

Safety and effectiveness of azelastine HCl nasal spray, 0.1% in pediatric patients below the age of 5 years with seasonal allergic rhinitis and in pediatric patients below the age of 12 years with ...

Objective: To compare loratadine with fexofenadine and placebo in relieving symptoms of seasonal allergic rhinitis (SAR). Design: A randomised, double-blind, double-dummy, placebo-controlled ...

Nasal steroids provided the most significant benefit, especially when compared to montelukast. Nasal antihistamines also performed better than oral antihistamines, making sprays the top choice for ...